Evaluation of the Medical Service by Socio-aesthetics in Oncology
Launched by CENTRE HOSPITALIER DE VALENCE · Sep 6, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, named "Evaluation of the Medical Service by Socio-aesthetics in Oncology," is studying how a specific type of care, called socio-aesthetics well-being care, can help improve the quality of life for people undergoing treatment for different kinds of cancer, including lung, breast, colon, and prostate cancers. The goal is to see if this type of care can make patients feel better during their treatment compared to just using skincare products on their own. Researchers will also look at whether this care helps to reduce feelings of anxiety and pain.
To be eligible for this study, participants need to be over 18 years old and currently receiving chemotherapy for one of the mentioned cancers. They should be able to read and write in French and be part of a social security program. It’s important that participants can commit to the study for its duration and have signed an informed consent form. The trial is not yet recruiting, but once it starts, participants can expect to receive special care focused on their well-being, along with regular check-ins about their health and feelings during treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • over 18 years old
- • treated with chemotherapy for lung , breast, colon or prostate cancer
- • Able to understand, read, and write French,
- • Affiliated with a social security scheme,
- • Having dated and signed an informed consent.
- Exclusion Criteria:
- • Unable to be followed for medical, social, family, geographic or psychological reasons for the duration of the study,
- • Deprived of their liberty by court or administrative decision,
About Centre Hospitalier De Valence
Centre Hospitalier de Valence is a leading healthcare institution dedicated to advancing medical research and patient care through innovative clinical trials. With a strong commitment to enhancing treatment options and improving patient outcomes, the center collaborates with multidisciplinary teams of healthcare professionals and researchers. It focuses on a wide range of therapeutic areas, leveraging state-of-the-art facilities and a patient-centered approach to ensure ethical and efficient study conduct. By prioritizing safety and scientific rigor, Centre Hospitalier de Valence aims to contribute significantly to the evolving landscape of healthcare and medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, , France
Tours, , France
Paris, , France
Patients applied
Trial Officials
Guillaume Guillaume
Principal Investigator
CH VALENCE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported